Literature DB >> 31672284

Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.

Cheng-Han Chung1, Alexander G Allen1, Neil T Sullivan1, Andrew Atkins1, Michael R Nonnemacher2, Brian Wigdahl3, Will Dampier4.   

Abstract

Defining the variables that impact the specificity of CRISPR/Cas9 has been a major research focus. Whereas sequence complementarity between guide RNA and target DNA substantially dictates cleavage efficiency, DNA accessibility of the targeted loci has also been hypothesized to be an important factor. In this study, functional data from two genome-wide assays, genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq) and circularization for in vitro reporting of cleavage effects by sequencing (CIRCLE-seq), have been computationally analyzed in conjunction with DNA accessibility determined via DNase I-hypersensitive sequencing from the Encyclopedia of DNA Elements (ENCODE) Database and transcriptome from the Sequence Read Archive to determine whether cellular factors influence CRISPR-induced cleavage efficiency. CIRCLE-seq and GUIDE-seq datasets were selected to represent the absence and presence of cellular factors, respectively. Data analysis revealed that correlations between sequence similarity and CRISPR-induced cleavage frequency were altered by the presence of cellular factors that modulated the level of DNA accessibility. The above-mentioned correlation was abolished when cleavage sites were located in less accessible regions. Furthermore, CRISPR-mediated edits were permissive even at regions that were insufficient for most endogenous genes to be expressed. These results provide a strong basis to dissect the contribution of local chromatin modulation markers on CRISPR-induced cleavage efficiency.
Copyright © 2019 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Keywords:  CIRCLE-seq; CRISPR; DNase-seq; GUIDE-seq; RNA-seq; bioinformatics; chromatin

Year:  2019        PMID: 31672284      PMCID: PMC6953893          DOI: 10.1016/j.ymthe.2019.10.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  68 in total

Review 1.  The role of chromatin during transcription.

Authors:  Bing Li; Michael Carey; Jerry L Workman
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

2.  R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters.

Authors:  Paul A Ginno; Paul L Lott; Holly C Christensen; Ian Korf; Frédéric Chédin
Journal:  Mol Cell       Date:  2012-03-01       Impact factor: 17.970

3.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

Review 4.  HIV-1 Latency and Eradication: Past, Present and Future.

Authors:  Prasun K Datta; Rafal Kaminski; Wenhui Hu; Vanessa Pirrone; Neil T Sullivan; Michael R Nonnemacher; Will Dampier; Brian Wigdahl; Kamel Khalili
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

5.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

Review 6.  HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.

Authors:  Angela Battistini; Marco Sgarbanti
Journal:  Viruses       Date:  2014-04-14       Impact factor: 5.048

7.  Chromatin accessibility pre-determines glucocorticoid receptor binding patterns.

Authors:  Sam John; Peter J Sabo; Robert E Thurman; Myong-Hee Sung; Simon C Biddie; Thomas A Johnson; Gordon L Hager; John A Stamatoyannopoulos
Journal:  Nat Genet       Date:  2011-01-23       Impact factor: 38.330

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

Authors:  Samuel H Sternberg; Sy Redding; Martin Jinek; Eric C Greene; Jennifer A Doudna
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

10.  Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.

Authors:  Benjamin P Kleinstiver; Shengdar Q Tsai; Michelle S Prew; Nhu T Nguyen; Moira M Welch; Jose M Lopez; Zachary R McCaw; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2016-06-27       Impact factor: 54.908

View more
  7 in total

1.  Massively targeted evaluation of therapeutic CRISPR off-targets in cells.

Authors:  Xiaoguang Pan; Kunli Qu; Hao Yuan; Xi Xiang; Christian Anthon; Liubov Pashkova; Xue Liang; Peng Han; Giulia I Corsi; Fengping Xu; Ping Liu; Jiayan Zhong; Yan Zhou; Tao Ma; Hui Jiang; Junnian Liu; Jian Wang; Niels Jessen; Lars Bolund; Huanming Yang; Xun Xu; George M Church; Jan Gorodkin; Lin Lin; Yonglun Luo
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

Review 2.  Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing.

Authors:  Neil T Sullivan; Alexander G Allen; Andrew J Atkins; Cheng-Han Chung; Will Dampier; Michael R Nonnemacher; Brian Wigdahl
Journal:  Front Microbiol       Date:  2020-08-12       Impact factor: 5.640

3.  Evaluation of CRISPR gene-editing tools in zebrafish.

Authors:  José M Uribe-Salazar; Gulhan Kaya; Aadithya Sekar; KaeChandra Weyenberg; Cole Ingamells; Megan Y Dennis
Journal:  BMC Genomics       Date:  2022-01-06       Impact factor: 4.547

Review 4.  Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy.

Authors:  Hager Mohamed; Theodore Gurrola; Rachel Berman; Mackenzie Collins; Ilker K Sariyer; Michael R Nonnemacher; Brian Wigdahl
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

5.  Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.

Authors:  Cheng-Han Chung; Alexander G Allen; Andrew J Atkins; Neil T Sullivan; Greg Homan; Robert Costello; Rebekah Madrid; Michael R Nonnemacher; Will Dampier; Brian Wigdahl
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-15       Impact factor: 8.886

6.  Multiplexed tat-Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape.

Authors:  Youdiil Ophinni; Sayaka Miki; Yoshitake Hayashi; Masanori Kameoka
Journal:  Viruses       Date:  2020-10-28       Impact factor: 5.048

7.  A novel fungal gene regulation system based on inducible VPR-dCas9 and nucleosome map-guided sgRNA positioning.

Authors:  Andreas Schüller; Lisa Wolansky; Harald Berger; Lena Studt; Agnieszka Gacek-Matthews; Michael Sulyok; Joseph Strauss
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-02       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.